Evidence to date shows that HCC generally involves a range of disruptions of the PI3K/MAPK pathways and the p53 network that includes cell cycle controls (RB1), as well as increased WNT signaling and the inactivation of key tumor suppressors (SOCSI) in the JAK/STAT network [18,19]. This evidence concerns the gene RB1 and hepatocellular carcinoma.